共 50 条
- [41] A randomized phase III trial of concurrent chemoradiation in locally advanced cervical cancer: preliminary results[J]. EJC SUPPLEMENTS, 2005, 3 (02): : 260 - 260Veerasarn, V.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandLorvidhaya, V.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandSuntornpong, N.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandSukthomya, V.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandSangruchi, S.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandChitapanarux, I.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandLertsanguansinchai, P.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandKhorprasert, C.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandSookpreedee, L.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, ThailandUdompunturak, S.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand
- [42] Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial[J]. ANNALS OF ONCOLOGY, 2017, 28Machiels, J-P.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ St Luc, Oncol, Brussels, Belgium Clin Univ St Luc, Oncol, Brussels, BelgiumLicitra, L.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS, Ist Nazl Tumori Milano, Oncol, Milan, Italy Clin Univ St Luc, Oncol, Brussels, BelgiumRischin, D.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Oncol, East Melbourne, Australia Clin Univ St Luc, Oncol, Brussels, BelgiumWaldron, J.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Oncol, Toronto, ON, Canada Clin Univ St Luc, Oncol, Brussels, BelgiumBurtness, B.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Sch Med, Med, New Haven, CT 06510 USA Clin Univ St Luc, Oncol, Brussels, BelgiumGregoire, V.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ St Luc, Oncol, Brussels, Belgium Clin Univ St Luc, Oncol, Brussels, BelgiumShekar, T.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ 07033 USA Clin Univ St Luc, Oncol, Brussels, BelgiumBrown, H. M.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ 07033 USA Clin Univ St Luc, Oncol, Brussels, BelgiumCheng, J.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ 07033 USA Clin Univ St Luc, Oncol, Brussels, BelgiumSiu, L. L.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada Clin Univ St Luc, Oncol, Brussels, Belgium
- [43] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Hong, Min Hee论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaKim, HyeRyun论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaPark, Seong Yong论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaKim, Dae Joon论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaLee, Chang Geol论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaCho, Jaeho论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaKim, Jong Hoon论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaKim, Hyeong Ryul论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaKim, Yong-Hee论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaPark, Sook Ryun论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South KoreaCho, Byoung Chul论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South Korea
- [44] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)[J]. ANNALS OF ONCOLOGY, 2019, 30Lee, S.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaAhn, B. C.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaPark, S. Y.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaKim, D. J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaLee, C. G.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaCho, J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaKim, J. H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaKim, H. R.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasular Surg, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaKim, Y-H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasular Surg, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaPark, S. R.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaChun, Y. J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea论文数: 引用数: h-index:机构:Kim, H. R.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasular Surg, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South KoreaCho, B.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea
- [45] KEYNOTE-966 trial in progress: Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer[J]. ANNALS OF ONCOLOGY, 2020, 31 : S270 - S271Valle, J. W.论文数: 0 引用数: 0 h-index: 0机构: Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, England Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandKelley, R. K.论文数: 0 引用数: 0 h-index: 0机构: UCSF, Div Hematol Oncol, San Francisco, CA USA Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandFuruse, J.论文数: 0 引用数: 0 h-index: 0机构: Kyorin Univ Hosp, Dept Med Oncol, Tokyo, Japan Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandEdeline, J.论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Med Oncol, Rennes, France Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandFinn, R. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandRen, Z.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Liver Surg, Shanghai, Peoples R China Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandSu, S-C.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandMalhotra, U.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandSiegel, A. B.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Med Oncol, Kenilworth, NJ USA Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, EnglandVogel, A.论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany Univ Manchester, Div Canc Sci, Christie NHS Fdn Trust, Manchester, Lancs, England
- [46] Neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced cervical cancer (NACI): A prospective, single-arm, phase II trial[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S804 - S804Chen, J.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaLi, K.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaHan, Y.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaShen, Y.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Obstet & Gynecol Hosp, Med Coll, Obstet & Gynaecol, Hangzhou, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Army Med Univ, Mil Med Univ 3, Southwest Hosp, Obstet & Gynaecol, Chongqing, Peoples R China Tianjin Med Univ, Gen Hosp, Gynecol Dept, Tianjin, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaSong, K.论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Qilu Hosp, Dept Obstet & Gynaecol, Jinan, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaChen, X.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Obstet & Gynaecol Hosp, Gynecol Dept, Shanghai, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaXia, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Gynecol Oncol, Hefei, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaZou, D.论文数: 0 引用数: 0 h-index: 0机构: Chongqing Canc Hosp, Dept Gynaecol Oncol, Chongqing, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Army Med Univ, Mil Med Univ 3, Southwest Hosp, Obstet & Gynaecol, Chongqing, Peoples R China Tianjin Med Univ, Gen Hosp, Gynecol Dept, Tianjin, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R ChinaMa, D.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
- [47] Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S9 - S10Jabbour, S. K.论文数: 0 引用数: 0 h-index: 0机构: Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USALee, K. H.论文数: 0 引用数: 0 h-index: 0机构: Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAFrost, N.论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany Corp member Freie Univ Berlin, Berlin, Germany Humboldt Univ, Berlin, Germany Berlin Inst Hlth, Berlin, Germany Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USABreder, V.论文数: 0 引用数: 0 h-index: 0机构: NN Blokhin Russian Canc Res Ctr, Moscow, Russia Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAKowalski, D.论文数: 0 引用数: 0 h-index: 0机构: Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAAlawin, I.论文数: 0 引用数: 0 h-index: 0机构: SouthWestern Reg Med Ctr Inc, Canc Treatment Centers Amer, Tulsa, OK USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USALevchenko, E.论文数: 0 引用数: 0 h-index: 0机构: Petrov Res Inst Oncol, St Petersburg, Russia Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAReguart, N.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAMartinez-Marti, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Barcelona, Spain Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAHoughton, B.论文数: 0 引用数: 0 h-index: 0机构: Port Macquarie Base Hosp, Mid North Coast Canc Inst, Port Macquarie, NSW, Australia Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAPaoli, J. B.论文数: 0 引用数: 0 h-index: 0机构: Clin Clairval, Radiotherapie, Marseille, France Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USASafina, S.论文数: 0 引用数: 0 h-index: 0机构: Republican Dispensary Tatarstan MoH, Med Oncol, Kazan, Russia Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAPark, K.论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Oncol Samsung Med Ctr, Div Hematol, Seoul, South Korea Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAKomiya, T.论文数: 0 引用数: 0 h-index: 0机构: Parkview Canc Inst, Hematol Med Oncol, Ft Wayne, IN USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USASanford, A.论文数: 0 引用数: 0 h-index: 0机构: Sanford Hlth, Sioux Falls, SD USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USABoolell, V.论文数: 0 引用数: 0 h-index: 0机构: Ballarat Hlth Serv, Ballarat, Vic, Australia Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USALiu, H.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USASamkari, A.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAKeller, S.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USAReck, M.论文数: 0 引用数: 0 h-index: 0机构: Lungen Clin Grosshansdorf, Airway Res Ctr North ARCN, German Ctr Lung Res DZL, Grosshansdorf, Germany Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
- [48] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Chen, Jing论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaLi, Kezhen论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaHu, Yingjie论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaHan, Yingyan论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaShen, Yuanming论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaWang, Yanzhou论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaSong, Kun论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaXia, Bairong论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaChen, Xiaojun论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaZou, Dongling论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaWang, Yingmei论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaSun, Chaoyang论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaChen, Gang论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R ChinaMa, Ding论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R China
- [49] A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer[J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3785 - 3792Lu, Heming论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaWu, Yuying论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gynecol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaLiu, Xu论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaJiang, Hailan论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaPang, Qiang论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaPeng, Luxing论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaCheng, Jinjian论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaDeng, Shan论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaGu, Junzhao论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaZhao, Renfeng论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gynecol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaHu, Xiaoxia论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gynecol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaChen, Changyi论文数: 0 引用数: 0 h-index: 0机构: Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gynecol, Nanning, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R ChinaYu, Jinming论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China
- [50] Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer A Nonrandomized Controlled Trial[J]. JAMA ONCOLOGY, 2020, 6 (06) : 848 - 855Jabbour, Salma K.论文数: 0 引用数: 0 h-index: 0机构: Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USABerman, Abigail T.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Radiat Oncol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USADecker, Roy H.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Dept Therapeut Radiol, Smilow Canc Ctr, Yale Sch Med, New Haven, CT USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USALin, Yong论文数: 0 引用数: 0 h-index: 0机构: Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA Rutgers Sch Publ Hlth, Dept Biostat & Epidemiol, Piscataway, NJ USA Rutgers State Univ, Div Biometr, Rutgers Canc Inst New Jersey, Piscataway, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USAFeigenberg, Steven J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Radiat Oncol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USAGettinger, Scott N.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Dept Med, Sect Med Oncol, Smilow Canc Ctr,Yale Sch Med, New Haven, CT 06520 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USAAggarwal, Charu论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Med, Div Hematol Oncol, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USALanger, Corey J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Med, Div Hematol Oncol, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USASimone, Charles B., II论文数: 0 引用数: 0 h-index: 0机构: New York Proton Ctr, Dept Radiat Oncol, New York, NY USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USABradley, Jeffrey D.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Emory Sch Med, Atlanta, GA 30322 USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USAAisner, Joseph论文数: 0 引用数: 0 h-index: 0机构: Rutgers State Univ, Div Med Oncol, Rutgers Canc Inst New Jersey, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USAMalhotra, Jyoti论文数: 0 引用数: 0 h-index: 0机构: Rutgers State Univ, Div Med Oncol, Rutgers Canc Inst New Jersey, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA Rutgers State Univ, Rutgers Canc Inst New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA